This section hosts guidelines, manuals and toolkits to strengthen public health practice.
The first non-prescription COVID-19 test that also detects the flu and RSV is discussed in this article. The FDA has approved the first non-prescription diagnostic test that can recognize several viruses, including respiratory syncytial virus, that cause respiratory symptoms similar to COVID-19 (RSV). FDA experts regard it as a further development toward the ability to diagnose certain infections at home. Customers will be able to more readily establish whether they have RSV, influenza, or SARS-CoV-2 infection thanks to the multianalyte test. Following consultation with a medical practitioner, test findings can assist consumers in deciding whether they should self-isolate or take other health care measures. We are getting closer to tests for these viruses that might be completed totally at home because to the quick advancements being made in consumer access to diagnostic tests, including the ability to collect your sample at home for the flu and RSV without a prescription.